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Osteoarthritis is one of the most frequent, disabling, and costly pathologies of modern
society. Among the main aims of osteoarthritis management are pain control and
functional ability improvement. The exact cause of osteoarthritis pain remains
unclear. In addition to the pathological changes in articular structures, changes in
central pain processing or central sensitization appear to be involved in osteoarthritis
pain. The latter calls for a broader approach to the management of patients with
osteoarthritis. Yet, the scientific literature offers scant information addressing the
treatment of central sensitization, specifically in patients with osteoarthritis. Inter-
ventions such as cognitive-behavioral therapy and neuroscience education potentially
target cognitive-emotional sensitization (and descending facilitation), and centrally
acting drugs and exercise therapy can improve endogenous analgesia (descending
inhibition) in patients with osteoarthritis. Future studies should assess these new
treatment avenues.
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Osteoarthritis (OA) is one ofthe most common rheumato-logic conditions,1,2 affecting
more than 80% of the population
beyond the age of 55 years.3 Two of
the most commonly affected joints
are the knees and the hips, sharing a
predominantly load-bearing func-
tion.4 Individuals with OA often have
chronic pain, which causes a great
deal of disabilities and results in sig-
nificant health care costs.5 Unfortu-
nately, at present, both the causes
of the pain and the most effective
treatment have not yet been
established.6,7
Historically, OA pain has been con-
sidered a nociceptive pain related to
the degree of structural damage to
the affected joint. Because the carti-
lage, under normal physiological
conditions, is an avascular and aneu-
ral tissue, the issue of whether pain
could come from other joint struc-
tures was raised. Thus, OA pain has
been attributed to deformation of
the periarticular tissues8 and the sub-
chondral bone,9 increased intraosse-
ous pressure,10 synovial inflamma-
tion,11 and injuries to the bone
marrow.12 Osteoarthritis pain also
has been described as a chronic
inflammatory response,13 partly
caused by an up-regulation of
sodium ion (Na) channels14 and
local production of nitric oxide,
associated with the degeneration of
the joint cartilage.15
Recently, OA has been considered as
a hypertrophic arthritis6 to differen-
tiate it from the atrophic arthritis typ-
ical of rheumatoid arthritis. This dif-
ferentiation is due to the fact that,
apart from cell death of chondro-
cytes and loss of joint cartilage, the
production of new tissue has been
observed in OA, including fibrocarti-
lage. Hence, in an attempt of the
cartilage to regenerate, an increase
in protein synthesis by the chondro-
cytes has become evident, especially
in the initial stages.16 Moreover, the
osteochondral angiogenesis derived
from expression of growth factors
(eg, vascular endothelial growth fac-
tor, platelet-derived growth factor)
has been proposed as a factor that
could facilitate the chronicity of pain
in OA.17,18 Furthermore, the litera-
ture has described cases of patients
with OA with satisfactory results
after treating myofascial trigger
points, which indicates that muscu-
loskeletal tissues also may play a part
in the pain related to OA.19
Because OA is an incurable pathol-
ogy, therapeutic objectives usually
focus on maximizing the patients
function and quality of life, while
keeping pain under control and min-
imizing the adverse effects derived
from the use of medication.6,20,21
Nonsteroidal anti-inflammatory
drugs can be beneficial in initial
stages, but in time they become inef-
ficient, and the administration of
other medications such as amitripty-
line or gabapentin is more advis-
able.22 This phenomenon might be
related to the fact that chronic pain
in people with OA is related more to
neuroplastic changes in the nervous
system than to an inflammatory con-
dition of the joint.22 Those who do
not respond well to conservative
treatment usually end up with a pros-
thetic restoration of the affected
joint.20,21 However, surgery does not
always imply a complete resolution
of symptoms.23
OA Pain
The understanding of pain in OA and
of its modulation and treatment is
central to physical therapist practice,
as physical therapists usually manage
patients affected by this disease.
Although pain is a very common
complaint in people with OA, there
is scarce knowledge of the etiology
and mechanisms of OA pain and its
treatment by health care profession-
als.24 The general trend is for health
care professionals to consider OA
pain as a reliable “informant” of what
is happening at the peripheral tissue
level. Thus, greater joint degenera-
tion is considered to be associated
with greater pain. Nevertheless,
there are different arguments that
make it difficult to explain OA using
exclusively a “peripheral model” of
pain. It has been reported, for
instance, that radiological changes
identified in patients with OA are not
always consistent with pain,25–28
although some studies have demon-
strated this correlation.29,30 The
great inter-individual variability in
pain severity and the unclear rela-
tionship between pain and structural
damage have raised the issue of the
existence of other mechanisms
responsible for the pain in OA. At
present, peripheral sensitization
and especially central sensitization
have been proposed as 2 of the
mechanisms underlying pain in
OA,24,31,32 as in other chronic mus-
culoskeletal pain conditions.33,34
Indeed, there is a growing body of
research involving pain mechanisms
in OA being central pain mecha-
nisms, an issue discussed in several
recent reviews.6,24,31,32,34,35
Mechanisms involved in central sen-
sitization have been shown across
several chronic conditions, which
recently have been grouped together
under the term “central sensitivity
syndromes” (CSS).36,37 This novel
unifying concept is now emerging as
a single common set of central ner-
vous system (CNS) processes38 and
has been proposed to include
chronic painful conditions that are
based on central sensitization such
as fibromyalgia, irritable bowel syn-
drome, and temporomandibular dis-
order. Osteoarthritis pain is not cur-
rently included in the group of CSS
because the role of central sensitiza-
tion in OA is still in its infancy. Yet,
here we advocate that increasing evi-
dence supports the inclusion of OA
in the group of CSS. The hallmark of
these “centrally driven” pain condi-
tions is a diffuse hyperalgesic state
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identifiable using experimental sen-
sory testing (ie, quantitative sensory
testing39) and corroborated by func-
tional neuroimaging.40 The charac-
teristic symptoms of these central
pain conditions include multifocal
pain, fatigue, insomnia, memory dif-
ficulties, and a higher rate of comor-
bid mood disorders.36
Central sensitivity syndromes is an
important new concept that also
embraces the biopsychosocial model
of disease. In this sense, the OA pain
experience is multidimensional, fit-
ting well with the biopsychosocial
model, which reflects the influence
of biological (ie, structural changes),
psychological (ie, mood and cop-
ing), and social (ie, social support)
factors in the individual’s symptoms
and suffering. Several psychosocial
variables (eg, catastrophizing, high
level of depression, cognition about
pain) have been suggested as influ-
encing OA pain and disability.41 Psy-
chosocial interventions such as
cognitive-behavioral therapy (CBT)
or activity pacing may decrease
OA pain and disability.42–45 Some
studies addressing the effects of
combined physical and psychologi-
cal approaches in OA pain have been
conducted,46 and other studies are
still in progress.47
OA and Central
Sensitization
In the last few decades, great prog-
ress has been made in the knowl-
edge of pain. Currently, it is clear
that the majority of chronic muscu-
loskeletal pain conditions are char-
acterized by an alteration in pain
processing by the CNS.34 More spe-
cifically, sensitivity of central neu-
rons to inputs coming from the uni-
modal and polymodal receptors
increases, which results in a physio-
pathological condition called “cen-
tral sensitization,” characterized by a
general or extended hypersensitiv-
ity. Central sensitization is defined
as “an increased response of CNS
neurons which inform of pain when
faced with inputs coming from
low threshold mechanoreceptors.”48
However, central sensitization not
only refers to spinal cord sensitiza-
tion or amplification of the afferent
impulses coming from the periph-
ery. It also includes an alteration of
sensory processing in the brain,49
loss of descending antinociceptive
mechanisms,50 enhanced facilitatory
pain mechanisms, increased tempo-
ral summation or wind-up,51 and
long-term potentiation of neuronal
synapsis in the anterior cingulate
cortex.52 Pathophysiological mecha-
nisms underlying central sensitiza-
tion are complex and numerous, but
the net effect is an amplification of
neural signaling within the CNS that
elicits pain hypersensitivity.34
Central sensitization is present in dif-
ferent chronic musculoskeletal con-
ditions such as whiplash trauma,53
chronic low back pain,54 and fibro-
myalgia55 and, more recently, in
OA,6,24,31,32,35 which concerns us
here. One of the factors that favor
the development of central sensitiza-
tion in OA is the massive and repet-
itive nociceptive input coming from
peripheral joint nociceptors and
transmitted to dorsal horn neurons
in the spinal cord. Therefore, intense
and continued nociceptive input
proceeding from an OA joint may
cause central sensitization, as shown
in different studies.56–58 The pres-
ence of central sensitization entails
greater complexity of the clinical
picture59 and fewer possibilities of
achieving positive results with phys-
ical therapy treatment.60
Patients with OA often present
referred pain and changes in skin
sensitivity in remote areas with
respect to the affected joint. There
are various theories on referred pain,
but they all include a higher centers
misinterpretation of the peripheral
origin of nociception.61 Referred
pain is a phenomenon attributed to
central sensitization, so its presence
in OA is highly indicative of changes
in pain processing in the CNS.
Another phenomenon associated
with central sensitization is second-
ary hyperalgesia. Although primary
hyperalgesia or peripheral sensitiza-
tion involves an increased sensitivity
of peripheral nociceptors in
response to tissue damage, second-
ary hyperalgesia corresponds to
increased sensitivity of dorsal horn
neurons located in the spinal seg-
ments corresponding to the primary
nociceptive source. Peripheral sensi-
tization is a local phenomenon,
whereas secondary hyperalgesia is a
central process of the nervous sys-
tem. Regarding OA, different studies
have shown an increase in nocicep-
tive transmission in dorsal horn neu-
rons, typical of secondary hyperalge-
sia.62,63 Im et al7 provided key in vivo
evidence that OA pain is caused by
central sensitization through com-
munication between peripheral OA
nociceptors and the central sensory
system. They observed that struc-
tural changes in components of the
peripheral knee joint correlated with
alterations in the central compart-
ments (dorsal root ganglia and the
spinal cord) and symptomatic pain
assessed by behavioral hyperalgesia.
Apart from referred pain and second-
ary hyperalgesia, there is further evi-
dence in the scientific literature that
shows how pain in OA can be mod-
ulated through mechanisms related
to the CNS. It has been found, for
instance, that OA causes a decrease
in pain thresholds in not only the
affected joint, but also far from it in
remote and over extended areas.64,65
Loss of descending pain inhibitory
mechanisms,64,66 increase of tempo-
ral summation (increase of painful
response to repetitive stimulation),66
and the presence of extended areas
of hyperalgesia in patients with
OA66–68 further support the role of
central sensitization in OA pain.
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Moreover, it is important to remem-
ber that patients with chronic mus-
culoskeletal pain conditions usually
present generalized hyperalgesia in
deep tissues and an increased
response to experimental painful
stimulation.69,70
Recent evidence of the role central
sensitization plays in OA pain comes
from a study by Graven-Nielsen et
al,71 who conducted a protocol of
pain assessment in people with knee
OA. Widespread hyperesthesia,
enhanced spatial summation, and
loss of conditioned pain modulation
were observed, which imply sensi-
tized central pain mechanisms in
these patients. Moreover, all of these
measurements were normalized fol-
lowing joint replacement which
implies that these central pain pro-
cesses were maintained by periph-
eral input.
An animal study has shown the con-
tribution of the spinal glial cells to
central sensitization associated with
OA.72 Glial cells are crucial in the
onset and maintenance of central
sensitization, especially in relation
to neuropathic pain. Activated glial
cells (microglia and astrocytes) in
the spinal cord can contribute to
central sensitization by producing
proinflammatory cytokines, comple-
ment factors, and cyclooxygenase
(COX) type 1 and 2 inside the CNS.
Their participation in OA pain indi-
cates that mechanisms underlying
neuropathic and OA pain might be
similar22 Still, these animal observa-
tions require confirmation in human
studies.
One of the characteristics of central
sensitization is that, once installed, it
can persist in time despite the lack of
new painful stimuli from the periph-
ery. In clinical practice, it is not
uncommon to find patients with OA
who show symptoms even after
prosthetic substitution. It has been
noted that patients suffering with
OA and a high degree of pain and
low pain thresholds before surgery
run a greater risk of continued pain
after getting a prosthetic knee,
which has been interpreted as an
accurate reflection of central
sensitization.23
The effect of certain centrally acting
drugs such as duloxetine on OA
pain73,74 and the result of various
studies carried out with functional
magnetic resonance imaging (fMRI)
have further consolidated the role of
central sensitization in this pathol-
ogy. Duloxetine is a serotonin and
norepinephrine reuptake inhibitor
drug that activates descending nor-
adrenergic descending pathways
together with serotonergic path-
ways.75 Functional magnetic reso-
nance imaging is a valid test that
identifies how and where the pain
is processed in the brain and how
this process varies for different
patients.76,77 Studies using fMRI have
shown an increased activity of the
periaqueductal gray in patients with
OA in comparison with individuals
who are healthy.78 This finding has
been interpreted as increased activ-
ity of descending facilitatory pain
mechanisms (a mechanism with the
same net effect as decreased
descending analgesia). Pain of knee
OA is processed in areas related to
emotions and fears79 and activates
pain areas of the prefrontal limbic
region,80 which also is typical of
other chronic musculoskeletal con-
ditions such as low back pain.81
These areas are involved in the emo-
tional evaluation of a person’s sur-
roundings,82 thus confirming that
chronic pain is an emotional state.
This view applies to OA pain, as
noted by Kulkarni et al.79 The Table
summarizes the currently available
evidence regarding central sensitiza-
tion in OA pain.
With regard to central sensitization
in patients with OA pain, there is still
much to discover. Notably, we need
to determine which contributing
genetic and environmental factors
increase the risk of developing cen-
tral sensitization, precisely what trig-
gers and maintains this phenome-
non, and what is the responsible
factor of its persistence in some indi-
viduals.34 However, identifying the
contribution of central sensitization
to many painful clinical condi-
tions, “inexplicable” until the last
couple of years,34 has marked an
important shift in physical thera-
pists’ clinical reasoning and has
favored the development of new
therapeutic strategies.83
Identification of Central
Sensitization in Patients
With OA
For some physical therapists, central
sensitization is a theoretical concept,
difficult to apply in daily clinical
practice. Some therapists have even
come to believe that it is a phenom-
enon that can rarely occur in their
patients, which contradicts reality.
Unfortunately, there is currently nei-
ther an international consensus defi-
nition nor a set of valid clinical cri-
teria for the diagnosis of central
sensitization. In other words, the
diagnosis of central sensitization in
patients with chronic musculoskele-
tal pain cannot be given directly, and
clinicians should rely on symptoms
and signs suggestive of central sensi-
tization pain.
A recent study has shown how phys-
ical therapists can use information
obtained from the medical diagnosis,
patient’s medical record, physical
examination, and treatment
response to clinically identify central
sensitization in patients with muscu-
loskeletal pain.84 Not all patients
with OA are characterized by central
sensitization, thus probably consti-
tuting a subgroup within this pathol-
ogy.85 Murphy et al85 identified, in a
heterogeneous sample of patients
with hip and knee OA, a small sub-
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group (36%) with symptoms suggest-
ing central sensitization (widespread
pain, fatigue, sleep disturbance, and
cognitive difficulties). However, no
attempt was made to determine
whether those symptoms were man-
ifestations of OA or other comorbid
conditions such as fibromyalgia. In a
recent study, Murphy et al86 showed
how 27% of the variance in pain
severity in women with knee OA
was explained by age, radiographic
severity, and centrally mediated
symptoms. Centrally mediated symp-
toms explained an additional 10% of
the variance in pain severity after the
other 2 variables were entered into
the analysis. Both radiographic sever-
ity and centrally mediated symptoms
were independently and significantly
associated with pain severity. In
addition to more severe radiographic
features, women with higher cen-
trally mediated symptoms had
greater pain severity.
Although the studies by Murphy and
colleagues85,86 have provided some
evidence that patients with greater
central pain contributions can be
identified in routine clinical practice,
the implications of this involvement
in OA are just starting to be realized,
and larger longitudinal studies are
needed. Evidence-based strategies
are needed to more readily and sys-
tematically identify these patients.
Guidelines for the recognition of
central sensitization in patients with
musculoskeletal pain such as OA
pain have been presented84 and are
currently being updated and
upgraded toward the first interna-
tional diagnostic criteria for central
sensitization in patients with muscu-
loskeletal pain. Development of
these diagnostic criteria should rep-
resent an improvement in the field
and constitute an important step
toward facilitating the acknowledge-
Table.
Summary of Current Evidence Regarding Central Sensitization in Osteoarthritis Pain
Study
Year of
Publication
Experimental
Model
Joint Under
Study Evidence of Central Sensitization
O’Driscoll and Jayson65 1974 Human Hip Extended and remote areas of hyperalgesia from affected joint
Neugebauer et al57 1993 Animal Knee Dorsal horn sensitization (secondary hyperalgesia)
Kosek and Ordeberg64 2000 Human Hip Extended and remote areas of hyperalgesia from affected joint
Loss of descending pain inhibitory mechanisms
Bajaj et al67 2001 Human Lower extremity Extended and remote areas of hyperalgesia from affected joint
Sharif Naeini et al63 2005 Animal Ankle Dorsal horn sensitization (secondary hyperalgesia)
Ivanavicius et al22 2007 Animal Knee Contribution of spinal glial cells to pain
Kulkarni et al79 2007 Human Knee Functional magnetic resonance imaging (fMRI)
Martindale et al56 2007 Animal Knee Dorsal horn sensitization (secondary hyperalgesia)
Pinto et al62 2007 Animal Ankle Dorsal horn sensitization (secondary hyperalgesia)
Imamura et al68 2008 Human Knee Extended and remote areas of hyperalgesia from affected joint
Lundband et al23 2008 Human Knee Persistence of pain after prosthetic substitution
Chappell et al73 2009 Human Knee Positive effects of centrally acting drugs
Gwilym et al78 2009 Human Hip fMRI
Arendt-Nielsen et al66 2010 Human Knee Extended and remote areas of hyperalgesia from affected joint
Loss of descending pain inhibitory mechanisms
Im et al7 2010 Animal Knee Communication between peripheral OA nociceptors and the
central sensory system
Hochman et al97 2010 Human Knee Neuropathic pain descriptors of symptoms
Abou-Raya et al74 2011 Human Knee Positive effects of centrally acting drugs
Parks et al80 2011 Human Knee fMRI
Murphy et al85 2011 Human Knee/hip Identification of subgroup of patients with symptoms
suggesting central sensitization
Murphy et al86 2011 Human Knee Identification of subgroup of patients with symptoms
suggesting central sensitization
Sagar et al72 2011 Animal Ankle Contribution of spinal glial cells to pain
Hochman et al98 2011 Human Knee Neuropathic pain descriptors of symptoms
Graven-Nielsen et al71 2012 Human Knee Widespread hyperesthesia, enhanced spatial summation, and
loss of conditioned pain modulation
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ment and recognition of central sen-
sitization as a disease.
Some classification systems based on
pain mechanisms are described in
scientific literature.87–91 In them, a
classification of the patient’s pain is
attempted according to the neuro-
physiological mechanism responsi-
ble for the generation or mainte-
nance of pain.90–93 Therefore,
starting with a set of signs and symp-
toms, patients are classified in 3
groups: (1) those with nociceptive
pain, (2) those with peripheral neu-
ropathic pain, and (3) those with
pain due to central sensitization.
This classification system, in theory,
allows us to establish the most ade-
quate treatment strategy and
improve outcomes.87 One of the
advantages of such classifications is
that they offer a better explanation
of variations observed in the nature
and severity of many clinical presen-
tations of musculoskeletal pain disor-
ders such as OA, where pain can be
present without pathology, pathol-
ogy without pain, or persistent pain
despite resolution of pathology. Reli-
ability and discriminating validity of
these classification systems have
been documented recently in rela-
tion to lower back and lower-limb
pain.94–96 However, whether these
results can be extrapolated to a pop-
ulation with OA is unknown.
Central sensitization also has been
inferred from OA in humans in terms
of neuropathic pain descriptors of
symptoms. Hochman et al97 recently
identified in a sample of people with
chronic pain due to knee OA, a small
subgroup who used subjective
descriptors of pain suggesting neuro-
pathic pain. The neuropathic pain
subgroup mainly comprised young
women with greater pain intensity
and severity and longer duration of
pain.97 Using specific questionnaires
also allowed identification of a neu-
ropathic pain component in patients
with OA.98
In order to understand exactly the
role central sensitization plays in
patients with OA, it could prove use-
ful to evaluate the response to inter-
ventions specifically addressing alter-
ations in central pain processing.
Moreover, patients with OA having
clear signs and symptoms of central
sensitization (eg, a patient with hip
OA having widespread pain, hyper-
sensitivity to bright light, and intol-
erance to stress) can be treated dif-
ferently. Once the physical therapist
concludes that central sensitization
rather than the local joint destruc-
tion dominates the clinical picture of
the patient with OA, the treatment
focus should be reset on the CNS
(ie, diminishing the hypersensitivity
of the CNS). Apart from pharmaco-
logical treatments mentioned above
(ie, centrally acting drugs), other
treatments addressing cognitive-
emotional sensitization such as CBT
or neuroscience education should be
take into consideration.99 However,
until now, these types of interven-
tions have been underestimated in
patients with OA.100 Finally, educa-
tion can be combined with graded
exercise therapy/graded activity and
stress management to design a com-
prehensive rehabilitation program
targeting central sensitization in
patients with OA. These interven-
tions are explained below.
Neuroscience Education:
A Future Tool in OA?
Traditional rehabilitation treatments
for OA typically are directed to the
periphery (ie, joint and surrounding
structures) through interventions
such as joint injections, joint protec-
tion, analgesic medication, manual
therapy, exercise, or transcutaneous
electrical nerve stimulation. Tech-
niques used to manage pain such as
manual therapy,101,102 exercise, or
transcutaneous electrical nerve stim-
ulation103 can potentially target cen-
tral sensitization by modulating pain
and desensitizing the CNS,35,99
although their effects on central sen-
sitization are unclear. Moreover,
therapeutic strategies addressing the
symptoms that accompany OA pain
(ie, sleep disturbance, depression,
and fatigue), such as CBT or CBT-
guided and activity pacing, could act
on central factors contributing to
pain in OA.
One intervention recently used to
desensitize CNS is neuroscience edu-
cation. Neuroscience education is an
educational intervention aiming to
reduce pain and disability by explain-
ing to the patient the biological pro-
cesses underlying his or her pain
condition. Its use is recommended in
central sensitization conditions,
where the patient presents maladap-
tive cognitions, behavior, or coping
strategies in response to pain.104 In
contrast to educational programs
commonly used in rehabilitation that
apply pathoanatomical and biome-
chanical models to explain the pain
(focusing on the tissues and tissue
damage), neuroscience education
describes how the nervous system
interprets information coming from
the tissues through peripheral sensi-
tization, central sensitization, synap-
tic activity, and cortical processing.
Conventional biomedical models not
only have a limited efficiency in
decreasing pain and disability,105,106
but they also can be counterproduc-
tive because they increase the
patient’s fear, anxiety, and stress,
which also can increase the
pain.107–109
From a clinical perspective, it is a
challenge to put into practice scien-
tific knowledge related to central
sensitization and chronic pain. Clin-
ical guides are now available that
provide information for explaining
central sensitization, describing how
to perform a neuroscience education
session with patients with chronic
musculoskeletal pain.104 A system-
atic review of the effect of neurosci-
ence education on pain, disability,
and stress in patients with chronic
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musculoskeletal pain has recently
been published.110 In this review, it
was concluded there is convincing
evidence that neuroscience educa-
tion has positive effects on pain, dis-
ability, catastrophizing, and physical
performance in patients with
chronic musculoskeletal pain. More-
over, structure, content, and evi-
dence of treatment with neurosci-
ence education for different chronic
conditions are described in detail
elsewhere.104,110 Nonetheless, one of
the limitations of this review is that
evidence exists only for very specific
pathologies such as chronic low
back pain, chronic fatigue syn-
drome, fibromyalgia, and chronic
whiplash trauma. It remains to be
established whether these findings
can be extrapolated to other muscu-
loskeletal pain conditions such as
OA. Hence, future studies should
specifically evaluate efficacy of inter-
ventions addressing psychosocial
aspects in OA such as neuroscience
education as has already been done
with CBT or activity pacing. More-
over, one of the challenges clinicians
are faced with is to find the perfect
balance, for each patient with OA,
between interventions directed at
musculoskeletal tissues and “hands-
off” approaches.111
It should be emphasized that neuro-
science education is not a treatment
but rather a strategy targeting cogni-
tive barriers for behavioral change
and hence effective physical ther-
apy. Neuroscience education aims at
reconceptualizing chronic pain in a
way that it is no longer regarded as
threatening (ie, the patient should
understand that pain in case of cen-
tral sensitization no longer reflects
tissue damage but rather reflects
“noise” in the sensory system). This
approach opens the avenue for a
time-contingent approach to exer-
cise therapy and activity manage-
ment, which is explained below.
Exercise Therapy and
Graded Activity
Exercise is frequently encountered
as a central component of the man-
agement of OA pain. Although the
clinical benefits of exercise therapy
in OA are well established (ie, evi-
dence based),112 it is currently
unclear whether exercise therapy
has positive effects on the processes
involved in central sensitization.
From a theoretical perspective, exer-
cise has the potential to “treat” the
process of central sensitization: exer-
cise activates brain-orchestrated
endogenous analgesia (reviewed in
Nijs et al113). From a clinical perspec-
tive, clinicians are advised to use a
time-contingent approach when
exercising patients with OA and
central sensitization. This approach
implies that the patient does not
cease exercise bouts once local pain
severity increases. Instead, the
patient adheres to the predeter-
mined exercise modalities (including
the time-contingent variable exer-
cise duration) and interprets pain
increases as nonthreatening.
Such a time-contingent approach is
unlikely to be effective unless the
patient applies this time-contingent
approach in daily life as well. Indeed,
graded activity is a behavioral ther-
apy applying such a time-contingent
approach in the daily life of patients
with OA. Increased physical activity
is effective for managing pain in
patients with OA who are over-
weight,114 and graded activity ther-
apy is effective for patients with OA
in general.115,116 Moreover, graded
activity results in better exercise
adherence and more physical activ-
ity compared with usual care in
patients with hip or knee OA, both
in the short term and the long
term.117
Conclusions
Osteoarthritis is a frequent chronic
musculoskeletal pathology that usu-
ally causes great disability and results
in significant health care costs. Even
though patients with OA present
structural anomalies, the severity of
these changes is not always propor-
tional to the degree of pain or dis-
ability. A significant proportion of
these patients show signs of central
sensitization, with pain modulation
and processing altered at the CNS
level. Substantial scientific evidence
indicates a role for central sensitiza-
tion in OA pain, yet it is necessary to
develop strategies to allow reliable
and systematic recognition of
patients with OA whose pain has a
central sensitization component.
Central sensitization management is
an area of great interest, at least in
the subgroup of patients with OA
pain having central sensitization.
Interventions such as CBT and neu-
roscience education potentially tar-
get cognitive-emotional sensitization
(and descending facilitation), and
centrally acting drugs and exercise
therapy can improve endogenous
analgesia (descending inhibition) in
patients with OA. However, to date,
evidence on both identification and
treatment of central sensitization in
OA is still scarce, and more human
research is needed.
Optimum treatment for people with
OA pain requires a multidisciplinary
approach and determination of how
peripheral and central factors are
contributing to pain in each patient
in order to enable individualization
of treatment strategies. Physical
therapists are well positioned to
deliver an individualized interven-
tion because they are cognizant of
the need for a biopsychosocial
approach to management. In addi-
tion, they can perform systematic
assessment and choose to utilize a
more peripheral or central-based
therapy.
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